ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma

Zhao, Chen*; Xiong, Kewei; Adam, Abdalla; Ji, Zhiqiang; Li, Xiangpan*山东大学; 武汉大学
Frontiers in Immunology2022-7-14DOI: 10.3389/fimmu.2022.934494
8被引10阅读
引用收藏
分享

摘要

This study aims to investigate the immune and epigenetic mutational landscape of necroptosis in lung adenocarcinoma (LUAD), identify novel molecular phenotypes, and develop a prognostic scoring system based on necroptosis regulatory molecules for a better understanding of the tumor immune microenvironment (TIME) in LUAD. Based on the Cancer Genome Atlas and Gene Expression Omnibus database, a total of 29 overlapped necroptosis-related genes were enrolled to classify patients into different necroptosis phenotypes using unsupervised consensus clustering. We systematically correlated the phenotypes with clinical features, immunocyte infiltrating levels, and epigenetic mutation characteristics. A novel scoring system was then constructed, termed NecroScore, to quantify necroptosis of LUAD by principal component analysis. Three distinct necroptosis phenotypes were confirmed. Two clusters with high expression of necroptosis-related regulators were "hot tumors", while another phenotype with low expression was a "cold tumor". Molecular characteristics, including mutational frequency and types, copy number variation, and regulon activity differed significantly among the subtypes. The NecroScore, as an independent prognostic factor (HR=1.086, 95%CI=1.040-1.133, p<0.001), was able to predict the survival outcomes and show that patients with higher scores experienced a poorer prognosis. It could also evaluate the responses to immunotherapy and chemotherapeutic efficiency.In conclusion, necroptosis-related molecules are correlated with genome diversity in pan-cancer, playing a significant role in forming the TIME of LUAD. Necroptosis phenotypes can distinguish different TIME and molecular features, and the NecroScore is a promising biomarker for predicting prognosis, as well as immuno- and chemotherapeutic benefits in LUAD.

学科与关键词

关键词
lung adenocarcinomanecroptosistumor immune microenvironmentimmunotherapymulti-omics
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-07-14
卷期
第 13 卷
页码
934494
DOI
10.3389/fimmu.2022.934494
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Hubei Province [2014CFB394, 2019CFB721]; Health and Family Planning Commission of Hubei Province [WJ2017M027]; Cisco hausen Cancer Research Foundation [Y-HS202101- 0079]

作者

  • Z

    Zhao, Chen (通讯) (第一作者)

    renmin hosp wuhan univ

  • X

    Xiong, Kewei

    renmin hosp wuhan univ · cent china normal univ

查看全部 5 位作者收起作者
  • A

    Adam, Abdalla

    wuhan univ

  • J

    Ji, Zhiqiang

    shandong univ

  • L

    Li, Xiangpan (通讯)

    renmin hosp wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417